Full Text View
Tabular View
No Study Results Posted
Related Studies
Treatment of Patients With Major Depressive Disorder With MK0869
This study has been completed.
Study NCT00048607   Information provided by Merck
First Received: November 4, 2002   Last Updated: May 7, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Major Depressive Disorder
Additional conditions recognized in this trial
Depression
Depressive Disorder
Depressive Disorder, Major
Disease
More general conditions related to this trial
Behavioral Symptoms
Mental Disorders
Mood Disorders
Pathologic Processes
Interventions listed in this trial
aprepitant
Comparator: paroxetine HCL
Comparator: Placebo (Unspecified)
Additional drug interventions recognized in this trial
Paroxetine
More general drug interventions related to this trial
Antidepressive Agents
Antidepressive Agents, Second-Generation
Antiemetics
Autonomic Agents
Central Nervous System Agents
Gastrointestinal Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Merck


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services